Drug Approval | November 21, 2025
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Element5’s Agentic AI platform will be integrated with the HCHB EHR
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Subscribe To Our Newsletter & Stay Updated
